All In Biotech

Drug Trial Radar · NCT05135286

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia

Last checked: Nov 19, 2026Latest source record: Aug 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 629 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

629

Actual

Start

Mar 15, 2022

Primary completion

Mar 13, 2025

Study completion Mar 13, 2025

Sponsor

Lead sponsor
Visus TherapeuticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 26, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Conditions

  • Presbyopia

Interventions

  • BRIMOCHOL™ PFDrug

    A single drop in each eye at a visit.

  • Carbachol PFDrug

    A single drop in each eye at a visit.

  • VehicleDrug

    A single drop in each eye at a visit.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in near VATime frame: Baseline Day 1

Locations

42 sites in 1 country. Site status is shown where the registry gives one.

  • Visus Therapeutics Investigative Site

    Chandler, Arizona

  • Visus Therapeutics Investigative Site

    Phoenix, Arizona

  • Visus Therapeutics Investigative Site

    Sun City, Arizona

  • Visus Therapeutics Investigative Site

    Glendale, California

  • Visus Therapeutics Investigative Site

    Inglewood, California

  • Visus Therapeutics Investigative Site

    Irvine, California

  • Visus Therapeutics Investigative Site

    Mission Hills, California

  • Visus Therapeutics Investigative Site

    Newport Beach, California

  • Visus Therapeutics Investigative Site

    Pasadena, California

  • Visus Therapeutics Investigative Site

    Santa Barbara, California

  • Visus Therapeutics Investigative Site

    Littleton, Colorado

  • Visus Therapeutics Investigative Site

    Danbury, Connecticut

  • Visus Therapeutics Investigative Site

    Crystal River, Florida

  • Visus Therapeutics Investigative Site

    Delray Beach, Florida

  • Visus Therapeutics Investigative Site

    Fort Lauderdale, Florida

  • Visus Therapeutics Investigative Site

    Jacksonville, Florida

  • Visus Therapeutics Investigative Site

    Largo, Florida

  • Visus Therapeutics Investigative Site

    Mt. Dora, Florida

  • Visus Therapeutics Investigative Site

    Lake Villa, Illinois

  • Visus Therapeutics Investigative Site

    Indianapolis, Indiana

  • Visus Therapeutics Investigative Site

    Louisville, Kentucky

  • Visus Therapeutics Investigative Site

    Bloomington, Minnesota

  • Visus Therapeutics Investigative Site

    Kansas City, Missouri

  • Visus Therapeutics Investigative Site

    St Louis, Missouri

  • Visus Therapeutics Investigative Site

    Henderson, Nevada

  • Visus Therapeutics Investigative Site

    Poughkeepsie, New York

  • Visus Therapeutics Investigative Site

    Garner, North Carolina

  • Visus Therapeutics Investigative Site

    West Fargo, North Dakota

  • Visus Therapeutics Investigative Site

    Powell, Ohio

  • Visus Therapeutics Investigative Site

    Portland, Oregon

  • Visus Therapeutics Investigative Site

    Cranberry Township, Pennsylvania

  • Visus Therapeutics Investigative Site

    Wilkes-Barre, Pennsylvania

  • Visus Therapeutics Investigative Site

    Sioux Falls, South Dakota

  • Visus Therapeutics Investigative Site

    Maryville, Tennessee

  • Visus Therapeutics Investigative Site

    Memphis, Tennessee

  • Visus Therapeutics Investigative Site

    Smyrna, Tennessee

  • Visus Therapeutics Investigative Site

    Hurst, Texas

  • Visus Therapeutics Investigative Site

    Lakeway, Texas

  • Visus Therapeutics Investigative Site

    San Antonio, Texas

  • Visus Therapeutics Investigative Site

    Draper, Utah

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.